Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | ANPEP | P15144 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | FLT1 | P17948 | 1/20 | 0.35 |
| ▸ | KDR | P35968 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28465404 | 0.81 | USP2 (0.39) | SMN1; SMN2KMT2AUSP2PKMANPEP | |
| SCHEMBL13304854 | 0.78 | KMT2A (0.65) | SMN1; SMN2KMT2APKMMAPTALDH1A1 | |
| SCHEMBL1449903 | 0.75 | RAB9A (0.55) | SMN1; SMN2KMT2AMAPTALDH1A1NPC1 | |
| SCHEMBL4831743 | 0.75 | HPGD (0.59) | KMT2AANPEPMAPTALDH1A1KDM4E | |
| SCHEMBL3258073 | 0.74 | RAB9A (0.42) | SMN1; SMN2KMT2APKMMAPTALDH1A1 | |
| SCHEMBL13304549 | 0.74 | ATM (0.46) | SMN1; SMN2GAA | |
| SCHEMBL1987585 | 0.72 | TSHR (0.49) | SMN1; SMN2PKMANPEPALDH1A1RAB9A | |
| SCHEMBL3238136 | 0.72 | LMNA (0.40) | KMT2APKMMAPTALDH1A1KDM4E | |
| SCHEMBL13304628 | 0.72 | NAMPT (0.44) | KMT2APKMMAPTALDH1A1KDM4E | |
| SCHEMBL7786621 | 0.72 | RAB9A (0.40) | SMN1; SMN2KMT2APKMMAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2192115-A1 | 1,3-dimethylbutylcarboxanilides for controlling undesirable micro-organisms | Bayer CropScience AG (DE) | 2010-06-02 | — | — | EP | disclosed |
| EP-2192115-A1 | 1,3-dimethylbutylcarboxanilides for controlling undesirable micro-organisms | Bayer CropScience AG (DE) | 2010-06-02 | — | — | EP | disclosed |
| US-20070196406-A1 | 1,3-Dimethylbutyl carboxanilides for controlling undesirable micro-organisms | BAYER CROPSCIENCE AG (DE) | 2007-08-23 | — | — | US | disclosed |
| US-20070196406-A1 | 1,3-Dimethylbutyl carboxanilides for controlling undesirable micro-organisms | BAYER CROPSCIENCE AG (DE) | 2007-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070196406-A1 | 1,3-Dimethylbutyl carboxanilides for controlling undesirable micro-organisms | MCRS1, MRM1, PADI1 | SMN1; SMN2 3729/4885KMT2A 1139/4885USP2 942/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.